VP/GCL, Early Clinical Development

Cornerstone Search Group has been retained by an attractive, growing Biotech with a patient and people-focused culture that is actively developing next-generation oncology targeted therapies.

The VP/Global Clinical Leader will be accountable for the clinical development of best-in-class oncology targeted therapies to treat multiple cancers. This VP/GCL will be a key strategic member of the Oncology clinical development team and will own/lead a novel asset/program in early-stage development (there is an opportunity to stay with this asset through later stages of development). This is an extremely rewarding Clinical leadership role where you will be able to influence and impact the development of best-in-class targeted therapies to help many cancer patients.

As VP/GCL, this person will serve as a key Oncology strategist and thought partner to the Research and Development oncology leaders bringing enterprise thinking, a strong external network, and state-of-the-art clinical knowledge to maximize the patient value of the Company’s innovative Oncology portfolio. You will report to an experienced CMO that is hands-on, straightforward, and very collaborative.

QUALIFICATIONS/REQUIREMENTS:

• M.D. degree required; Oncologist/Hematologist is preferred.
• Progressive oncology clinical development experience gained working in Industry.
• Proven experience in oncology drug development and regulatory sciences to lead early clinical programs through regulatory interactions, including FIH studies and IND.
• Strategic and hands-on management & operational experience leading global clinical development programs.
• Experience working with other functions including preclinical and late-stage clinical development and external collaborators.
• Strong leadership, communication, writing, and presentation skills with the ability to lead/manage/mentor other professionals.
• Team oriented, patient-value focused, goal-driven, organized, and highly collaborative.